Cytokines in Cancer Immunotherapy

Cold Spring Harbor Perspectives in Biology
Thomas A Waldmann

Abstract

Cytokines that control the immune response were shown to have efficacy in preclinical murine cancer models. Interferon (IFN)-α is approved for treatment of hairy cell leukemia, and interleukin (IL)-2 for the treatment of advanced melanoma and metastatic renal cancer. In addition, IL-12, IL-15, IL-21, and granulocyte macrophage colony-stimulating factor (GM-CSF) have been evaluated in clinical trials. However, the cytokines as monotherapy have not fulfilled their early promise because cytokines administered parenterally do not achieve sufficient concentrations in the tumor, are often associated with severe toxicities, and induce humoral or cellular checkpoints. To circumvent these impediments, cytokines are being investigated clinically in combination therapy with checkpoint inhibitors, anticancer monoclonal antibodies to increase the antibody-dependent cellular cytotoxicity (ADCC) of these antibodies, antibody cytokine fusion proteins, and anti-CD40 to facilitate tumor-specific immune responses.

References

Feb 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R QuesadaJ U Gutterman
Sep 1, 1988·CA: a Cancer Journal for Clinicians·D Goldstein, J Laszlo
Apr 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M Kirkwood, M S Ernstoff
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·S N ConstantinescuL M Pfeffer
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FyfeA C Louie
Apr 9, 1993·Cell·T Taniguchi, Y Minami
Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M KirkwoodR H Blum
Mar 1, 1996·The Journal of Experimental Medicine·M J Lenardo
Jan 1, 1996·Journal of Clinical Laboratory Analysis·R A Reisfeld, S D Gillies
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·J C BeckerR A Reisfeld
Jan 1, 1994·Journal of Viral Hepatitis·M MüllerI M Kerr
Mar 1, 1997·The Journal of Clinical Investigation·W E CarsonM A Caligiuri
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·S DamjanovichT A Waldmann
May 23, 1998·Annual Review of Immunology·W J Leonard, J J O'Shea
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B AtkinsS A Rosenberg
Mar 8, 2000·The Journal of Experimental Medicine·M K KennedyJ J Peschon
Mar 29, 2000·British Journal of Cancer·G H WindbichlerC Marth
Jun 14, 2000·Immunologic Research·H N Lode, R A Reisfeld
Jul 6, 2000·The Journal of Clinical Investigation·T A FehnigerM A Caligiuri
Sep 28, 2000·Current Opinion in Immunology·N Mach, G Dranoff
Oct 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·J Marks-KonczalikY Tagaya
Jan 3, 2001·Blood·T A Fehniger, M A Caligiuri
Feb 27, 2001·Journal of Immunological Methods·M L Penichet, S L Morrison
May 22, 2001·The British Journal of Dermatology·S LeroyB Dréno
Sep 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S Ferrari-LacrazT B Strom

❮ Previous
Next ❯

Citations

Apr 18, 2018·Immunological Reviews·Miro E RaeberOnur Boyman
Apr 6, 2018·Journal for Immunotherapy of Cancer·Randy F SweisRussell Szmulewitz
Apr 21, 2018·International Journal of Molecular Sciences·Shike WangRen Xu
Jun 6, 2019·Chemical Society Reviews·Wei SangXiaoyuan Chen
Sep 4, 2019·The Journal of Clinical Investigation·Jonathan J HodginsMichele Ardolino
Sep 11, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rui P SousaJean-Yves Le Questel
Jan 24, 2020·Journal of Cellular Physiology·Ghasem Rahimi Kalateh Shah MohammadSeyed Isaac Hashemy
Apr 19, 2020·Journal for Immunotherapy of Cancer·Karin M KnudsonSofia R Gameiro
Jun 13, 2019·Journal of Hematology & Oncology·Hao WangXingxing Zang
Jul 10, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Corby FinkGregory A Dekaban
Sep 24, 2020·Immunological Reviews·Chirine RafiaEmmanuel Scotet
Aug 17, 2019·Frontiers in Immunology·Ana Luisa Palacios-AcedoLaurence Panicot-Dubois
Nov 5, 2019·Frontiers in Oncology·Oliviero MarinelliMassimo Nabissi
Jun 26, 2020·Frontiers in Cell and Developmental Biology·Daria S ChulpanovaValeriya V Solovyeva
Dec 26, 2018·Dermatology Research and Practice·Mehdi GhahartarsAbbas Ghaderi
Nov 11, 2018·British Journal of Cancer·Pedro BerraondoIgnacio Melero
Dec 11, 2019·The Journal of Experimental Medicine·Thomas A WaldmannKevin C Conlon
Jul 2, 2019·Asia-Pacific Journal of Oncology Nursing·Fedricker Diane Barber
May 20, 2020·Journal of Hematology & Oncology·Yonggui TianYi Zhang
Jun 7, 2020·Journal of Hematology & Oncology·Wenyu WangYong Sang Song
Sep 19, 2020·Cells·Ernesto BockampDetlef Schuppan
Jun 11, 2019·Frontiers in Oncology·Ondrej PalataIrena Adkins
Apr 15, 2020·Toxins·Robert D CarlsonAdam E Snook
Sep 17, 2020·Oncotarget·Victor Hugo de SouzaJeane Eliete Laguila Visentainer
Oct 6, 2020·Journal of Immunology Research·Liliana R BalahuraMarieta Costache
May 31, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·X DingK Ai
May 24, 2020·Antibodies·Josée Golay, Alain E Andrea
Feb 20, 2019·International Journal of Molecular Sciences·Catarina Roma-RodriguesAlexandra R Fernandes
Oct 1, 2019·Current Pharmaceutical Design·Alessandra IscaroMunitta Muthana
Jul 3, 2020·Nanomaterials·Vanessa Acebes-FernándezManuel Fuentes
Nov 25, 2020·Expert Opinion on Drug Discovery·Shunchuan Zhang, Samuel D Rabkin
Feb 19, 2020·Cancer Research·Ha-Ram ChaSelvarangan Ponnazhagan
Dec 22, 2020·Materials Horizons·Mohammad Mahdi Hasani-SadrabadiManish J Butte
Jan 16, 2021·Advanced Healthcare Materials·Anthony BrouillardAshish A Kulkarni
Jan 28, 2021·Cancers·Théo AccogliFrédérique Végran
Oct 20, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lisa MunakataTaiki Aoshi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.